| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 02/14/2007 | CN1911931A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 02/14/2007 | CN1911921A Method for identification of tumor targeting enzymes |
| 02/14/2007 | CN1911915A Lactam compound and medicinal use thereof |
| 02/14/2007 | CN1300147C Camptothecin derivatives preparing process |
| 02/14/2007 | CN1300146C Photochromic compound of spiro [indolerin-phenanthroline oxazine and its preparation and use |
| 02/14/2007 | CN1300145C Indole oxazine compound and its synthesis and use |
| 02/14/2007 | CN1299677C 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 02/13/2007 | US7176313 A oxoquinolines or a 4-oxo-1,8-naphthyridines or 7-oxo-7H-pyrido(1,2,3-de)(1,4)benzoxazine derivative for the treatment of tuberculosis, exhibits no cross resistance |
| 02/13/2007 | US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 02/13/2007 | US7176215 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 02/13/2007 | US7176214 Imidazo-fused oxazolo[4,5-β]pyridine and imidazo-fused thiazolo[4,5-β]pyridine based tricyclic compounds and pharmaceutical compositions comprising same |
| 02/13/2007 | US7176213 For example, 1-(9-benzylamino-10-cyano-imidazo[1,2-a]quinolin-2-carbonyl)pyrrolidine; may be used for the treatment of diseases such as asthma, glaucoma, tumors, allergic and inflammatory diseases, ischemia, hypoxia, arrythmia and renal diseases |
| 02/13/2007 | US7176196 Bicyclic heterocycles as HIV integrase inhibitors |
| 02/13/2007 | US7176195 Treatment of nocturnal enuresis, nocturia, polyuria resulting from central diabetes insipidus, urinary incontinence or bleeding disorders such a hemophilia |
| 02/08/2007 | WO2005103054A3 Bridged piperazine and piperidine derivatives as ccri antagonists |
| 02/08/2007 | US20070032640 Cytokine receptor |
| 02/08/2007 | US20070032518 Compounds and methods of use |
| 02/08/2007 | US20070032517 such as N-[3-acetyl-6-(4-chlorophenyl)-7-(2,4-dichlorophenyl)-1-methyl-2-oxo-1,2-dihydro-1,8-naphthyridin-4-yl]acetamide, used as selective antagonists of cannabinoid-1 receptors, useful in the treatment, prevention and suppression of nervous system disorders |
| 02/08/2007 | US20070032512 6,6-Bicyclic ring substituted sulfur containing heterobicyclic protein kinase inhibitors |
| 02/08/2007 | US20070032469 Tricyclic benzimidazoles and their use as metabotropic glutamate receptor modulators |
| 02/08/2007 | US20070031336 3H-phenoxazine derivatives suitable as near-infrared imaging agents, preparation an use thereof |
| 02/08/2007 | DE102005035527A1 Verwendung von Tetrahydrobenzoxazinen als Stabilisatoren Use of tetrahydrobenzoxazines as stabilizers |
| 02/08/2007 | CA2616337A1 Caspase inhibitor prodrugs |
| 02/07/2007 | EP1749012A1 Muscarinic acetylcholine receptor antagonists |
| 02/07/2007 | EP1749011A1 Bicyclic heterocycles as hiv integrase inhibitors |
| 02/07/2007 | EP1748980A1 Pyrrolidine derivatives as cb1-receptor antagonists |
| 02/07/2007 | EP1261336B1 Il-8 receptor antagonists |
| 02/07/2007 | CN1910172A 3-(dihydro(tetrahydro)isoquinolin-1-yl)quinolines |
| 02/07/2007 | CN1910164A Organic compounds |
| 02/07/2007 | CN1298722C Indole carbazole alkaloid and its preparing method and use |
| 02/07/2007 | CN1298715C Non-imidazole compounds as histamine H3 antagonists |
| 02/06/2007 | US7173051 Inhibitors of cathepsin S |
| 02/06/2007 | US7173022 Treatment of HIV integrase heterocycles for enzyme inhibitors and process of viricides |
| 02/06/2007 | CA2258662C Use of k-252a derivative for the treatment of peripheral or central nerve disorders, and cytokine overproduction |
| 02/01/2007 | WO2007013691A1 Spiro-cyclic compound |
| 02/01/2007 | WO2007013601A1 Labeling dye for biomolecule, labeling kit, and method for detecting biomolecule |
| 02/01/2007 | WO2007013017A1 A process for purification of macrolides |
| 02/01/2007 | WO2007012580A1 Use of tetrahydrobenzoxazines as stabilisers |
| 02/01/2007 | US20070027317 Hetero diels-alder adducts of pentacene as soluble precursors of pentacene |
| 02/01/2007 | US20070027185 inhibitor of factor Xa and/or thrombin; anticoagulantsto treat thromboembolic disorders, myocardial ischemia, myocardial infarction and cerebral thrombosis; N-(5-chloropyridin-2-yl)-3-[2-(piperidin-4-yloxy)-4-(pyrrolidin-1-yl)benzoylamino]pyridine-4-carboxamide; high bioavailability; acylation |
| 02/01/2007 | US20070027147 Biarylurea derivatives |
| 02/01/2007 | US20070027133 Bicyclic pyrazolyl and imidazolyl compounds and uses thereof |
| 02/01/2007 | US20070026036 Drug/Drug Delivery Systems for the Prevention and Treatment of Vascular Disease |
| 02/01/2007 | CA2617042A1 Spiro-cyclic compound |
| 02/01/2007 | CA2616675A1 Use of tetrahydrobenzoxazines as stabilizers |
| 01/31/2007 | EP1747774A1 Use of a composition comprising a colouring agent of the styrylic or imino type for dyeing keratinuous fibres |
| 01/31/2007 | EP1747221A1 Fused ring nk1 antagonists |
| 01/31/2007 | EP1746994A2 Thienopyridinone compounds and methods of treatment |
| 01/31/2007 | EP1478357B1 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 01/31/2007 | CN1906201A Methods of preparing olanzapine |
| 01/31/2007 | CN1905873A Bicyclic inhibitors of MEK and methods of use thereof |
| 01/31/2007 | CN1297559C Fused bicyclic pyrimidine derivatives |
| 01/31/2007 | CN1297555C Antagonists of MCP-q function and method of use thereof |
| 01/31/2007 | CN1297270C Ophthalmic composition comprising ascomycin |
| 01/30/2007 | US7169921 that bear a N-2-(alkoxycarbonylamino)ethyl substituent; intermediates in the synthesis of 1,3-diaza-6-oxa-adamantanes |
| 01/30/2007 | US7169786 Strong anti-depressant activity without being sedative; serotonin (5-HT) reuptake inhibitor activity in combination with additional alpha 2-adrenoceptor antagonist activity |
| 01/30/2007 | US7169594 detecting the presence or absence of increased S6 kinase activity in said biological sample. |
| 01/30/2007 | CA2350573C Piperidines as ccr5 modulators |
| 01/25/2007 | WO2007011022A1 3-(isoquinoline-1-yl)quinoline derivative |
| 01/25/2007 | WO2007009897A1 Biologically active compounds obtainable from sorangium cellulosum |
| 01/25/2007 | WO2006089298A3 Pyrimidine-fused diazepine derivatives and indole-fused pteridines |
| 01/25/2007 | US20070021605 Process and composition for making olanzapine form i |
| 01/25/2007 | US20070021476 Neuroprotectants; treatment of neuropathies resulting from chemtherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases; neurodegenerative diseases; enzyme inhibitors for seine/threonine kinases, phosphatases; Alzheimer' |
| 01/25/2007 | US20070021442 HIV reverse transcriptase inhibitors |
| 01/25/2007 | US20070021416 Imidazo[2,1-b]-1,3,4-thiadiazole sulfonamides |
| 01/25/2007 | CA2612482A1 Biologically active compounds obtainable from sorangium cellulosum |
| 01/24/2007 | EP1746100A1 Annelated carbamoylase-heterocycles, focused library, pharmaceutical compositions and methods for the production thereof |
| 01/24/2007 | EP1745784A1 Oxazolidinone derivatives and use thereof as antibiotics |
| 01/24/2007 | EP1745052A1 Hiv integrase inhibitors: cyclic pyrimidinone compounds |
| 01/24/2007 | EP1745051A1 Thienopyridazines as ikk inhibitors |
| 01/24/2007 | EP1745050A1 Thienopyridines as ikk inhibitors |
| 01/24/2007 | EP1745033A2 4,5-disubstituted-2-aryl pyrimidines |
| 01/24/2007 | EP1745009A1 Heteroaryl substituted cyclohexyl-1,4-diamine derivatives |
| 01/24/2007 | EP1404684B1 New picolinamine derivatives and their use a fungicides |
| 01/24/2007 | CN1902761A 有机薄膜晶体管 The organic thin film transistor |
| 01/24/2007 | CN1902206A Preparation of 1-aza-2-oxa-dibenzo [e,h] azulenes and their use for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders |
| 01/24/2007 | CN1902196A Thiazole derivative |
| 01/24/2007 | CN1902182A Macrocyclic lactams and pharmaceutical use thereof |
| 01/24/2007 | CN1900074A Substituted oxazolidinones and their use in the field of blood coagulation |
| 01/24/2007 | CN1296043C Use of formula I Rapamycin compound in preparing pharmaceutical composition for treating solid tumor |
| 01/23/2007 | US7166600 Resistant to metabolism, improved half-life and/or clearance properties compared to corresponding carbamates; e.g N-(2-chlorobenzoyl)-p-(morpholinothiocarbonyloxy)tyrosine; used to treat inflammatory diseases e.g rheumatoid arthritis, asthma, psoriasis, multiple sclerosis, inflammatory bowel disease |
| 01/23/2007 | US7166598 Piperazine derivatives |
| 01/23/2007 | US7166596 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 01/23/2007 | US7166583 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 01/23/2007 | US7166357 Substrate overcoated with photochromic layer; automobile windshield |
| 01/23/2007 | CA2239968C Pyrimidine derivatives and guanine derivatives, and their use in treating tumour cells |
| 01/23/2007 | CA2191747C (a)-annelated pyrrole derivatives and pharmaceutical use thereof |
| 01/18/2007 | WO2007009007A2 Methods of treatment using hydroquinone ansamycins |
| 01/18/2007 | WO2007007919A2 Heterocyclic janus kinase 3 inhibitors |
| 01/18/2007 | WO2007007072A1 5-htx modulators |
| 01/18/2007 | WO2007007040A1 2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes |
| 01/18/2007 | US20070015819 Novel compounds |
| 01/18/2007 | US20070015769 Use of 5ht4 receptor antagonists in the prophylaxis or treatment of certain cardiovascular conditions |
| 01/18/2007 | US20070015746 Azepine derivaties as pharmaceutical agents |
| 01/18/2007 | US20070015664 2,4,6-Phenyl substituted cyclic ketoenols |
| 01/18/2007 | CA2615291A1 Heterocyclic janus kinase 3 inhibitors |
| 01/18/2007 | CA2612506A1 Methods of treatment using hydroquinone ansamycins |
| 01/17/2007 | EP1743897A1 Biologically active compounds obtainable from Sorangium cellulosum |
| 01/17/2007 | EP1743884A1 Progrugs to d-prolines |
| 01/17/2007 | EP1743657A2 Stabilisation of macrolides |